Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,423 | 2,397 | 3,654 | 4,929 | 2,523 |
| Receivables | 477 | 485 | 489 | 242 | 248 |
| TOTAL | $2,065 | $2,936 | $4,233 | $5,331 | $2,984 |
| Non-Current Assets | |||||
| PPE Net | 428 | 312 | 235 | 252 | 287 |
| TOTAL | $428 | $312 | $235 | $252 | $287 |
| Total Assets | $2,493 | $3,248 | $4,468 | $5,583 | $3,271 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,739 | 1,418 | 715 | 816 | 389 |
| Accrued Expenses | 938 | 923 | 589 | 630 | 615 |
| TOTAL | $2,677 | $2,341 | $1,304 | $1,446 | $1,004 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $-1 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,676 | $2,341 | $1,304 | $1,446 | $1,004 |
| Shareholders' Equity | |||||
| Common Shares | 117,944 | 116,988 | 116,146 | 115,074 | 112,461 |
| Retained earnings | -151,226 | -148,608 | -145,321 | -142,717 | -140,474 |
| Other shareholders' equity | 10,186 | 10,548 | 10,549 | 10,748 | 11,296 |
| TOTAL | $-183 | $907 | $3,164 | $4,137 | $2,267 |
| Total Liabilities And Equity | $2,493 | $3,248 | $4,468 | $5,583 | $3,271 |